Search for other papers by M L Gild in
Google Scholar
PubMed
Search for other papers by M Bullock in
Google Scholar
PubMed
Search for other papers by C K Pon in
Google Scholar
PubMed
Cancer Genetics Laboratory, Department of Endocrinology, Kolling Institute of Medical Research, Sydney, New South Wales, Australia
Search for other papers by B G Robinson in
Google Scholar
PubMed
Cancer Genetics Laboratory, Department of Endocrinology, Kolling Institute of Medical Research, Sydney, New South Wales, Australia
Search for other papers by R J Clifton-Bligh in
Google Scholar
PubMed
signaling kinases. HSPs have become known as central regulators, whose actions are to control the activity of pathways such as cell proliferation and death, while preventing the aggregation of non-native proteins (1) . HSP90 is overexpressed in cancer cells
Search for other papers by Caiyan Mo in
Google Scholar
PubMed
Search for other papers by Tao Tong in
Google Scholar
PubMed
Search for other papers by Ying Guo in
Google Scholar
PubMed
Search for other papers by Zheng Li in
Google Scholar
PubMed
Search for other papers by Liyong Zhong in
Google Scholar
PubMed
commonly used in the treatment of patients with acromegaly and exerts central and direct effects on thyroid function. At the pituitary level, SSA inhibits thyrotropin cell proliferation and TSH secretion and can be used to treat TSH-secreting pituitary
Search for other papers by Róża Aleksandrowicz in
Google Scholar
PubMed
Search for other papers by Marek Strączkowski in
Google Scholar
PubMed
Supports processes such as proliferation, differentiation, and cell adhesion, ensures structural integrity of the ECM basement membrane, protects against injuries, takes part in muscle regeneration, and inhibits inflammation ( 9 , 14 , 20 , 21
Search for other papers by Yang Lv in
Google Scholar
PubMed
Search for other papers by Ning Pu in
Google Scholar
PubMed
Search for other papers by Wei-lin Mao in
Google Scholar
PubMed
Search for other papers by Wen-qi Chen in
Google Scholar
PubMed
Search for other papers by Huan-yu Wang in
Google Scholar
PubMed
Search for other papers by Xu Han in
Google Scholar
PubMed
Search for other papers by Yuan Ji in
Google Scholar
PubMed
Search for other papers by Lei Zhang in
Google Scholar
PubMed
Search for other papers by Da-yong Jin in
Google Scholar
PubMed
Search for other papers by Wen-Hui Lou in
Google Scholar
PubMed
Search for other papers by Xue-feng Xu in
Google Scholar
PubMed
over the last decades ( 1 ). The 2010 WHO classification utilized tumor proliferative ability (including Ki-67 proliferation index and mitotic rate) to divide NENs into three pathological grades: low grade (G1), intermediate grade (G2) and high grade (G
Faculté de Chirurgie Dentaire, Université de Toulouse III, Toulouse, France
Search for other papers by Emmanuelle Noirrit in
Google Scholar
PubMed
Search for other papers by Mélissa Buscato in
Google Scholar
PubMed
Search for other papers by Marion Dupuis in
Google Scholar
PubMed
CHU de Toulouse, Laboratoire d’Hématologie, Toulouse, France
Search for other papers by Bernard Payrastre in
Google Scholar
PubMed
Search for other papers by Coralie Fontaine in
Google Scholar
PubMed
Search for other papers by Jean-François Arnal in
Google Scholar
PubMed
Faculté de Chirurgie Dentaire, Université de Toulouse III, Toulouse, France
Search for other papers by Marie-Cécile Valera in
Google Scholar
PubMed
vehicle-treated controls BZA- and CE + BZA-treated mice ( Fig. 1A ). We then evaluated the changes of the structure of the vagina by histological analysis. Vaginal epithelial proliferation was evaluated by immunohistochemical detection of nuclear
Search for other papers by Melissa Braga in
Google Scholar
PubMed
Search for other papers by Zena Simmons in
Google Scholar
PubMed
Search for other papers by Keith C Norris in
Google Scholar
PubMed
Department of Health & Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, California, USA
Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
Search for other papers by Monica G Ferrini in
Google Scholar
PubMed
Department of Health & Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, California, USA
Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
Search for other papers by Jorge N Artaza in
Google Scholar
PubMed
nM) for 7 days. The dose of 1,25-D 3 used for these studies was derived from studies published by us and others on the effect of different concentrations of 1,25-D 3 at 3 and 4 days on the proliferation of C3H 10T 1/2 multipotent cells. In those
Research Center for Translational Medicine, Cancer Stem Cell Institute, East Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of China
Search for other papers by Shan Wu in
Google Scholar
PubMed
Search for other papers by Jianjun Zhou in
Google Scholar
PubMed
Search for other papers by Jing Guo in
Google Scholar
PubMed
Search for other papers by Zhan Hua in
Google Scholar
PubMed
Search for other papers by Jianchen Li in
Google Scholar
PubMed
Search for other papers by Zai Wang in
Google Scholar
PubMed
pathway has a critical role in angiogenesis, which indirectly mediates the underlying pathology and subsequent effects on cell proliferation, migration, permeability and survival of the vascular endothelium ( 6 , 7 ). As a crucial receptor for VEGF, KDR
Search for other papers by Xu Han in
Google Scholar
PubMed
Search for other papers by Xuefeng Xu in
Google Scholar
PubMed
Search for other papers by Hongyun Ma in
Google Scholar
PubMed
Search for other papers by Yuan Ji in
Google Scholar
PubMed
Search for other papers by Dansong Wang in
Google Scholar
PubMed
Search for other papers by Tiantao Kuang in
Google Scholar
PubMed
Search for other papers by Wenchuan Wu in
Google Scholar
PubMed
Search for other papers by Bin Song in
Google Scholar
PubMed
Search for other papers by Gang Li in
Google Scholar
PubMed
Search for other papers by Gang Jin in
Google Scholar
PubMed
Search for other papers by Wenhui Lou in
Google Scholar
PubMed
ability (both Ki-67 proliferation index and mitotic rate) to divide pNENs into 3 pathological grades: low grade (G1), intermediate grade (G2) and high-grade (G3). According to 2010 WHO classification scheme, high-grade pNENs are defined as a tumor with Ki
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Kirsty G Pringle in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Sarah J Delforce in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Yu Wang in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Katie A Ashton in
Google Scholar
PubMed
Search for other papers by Anthony Proietto in
Google Scholar
PubMed
Search for other papers by Geoffrey Otton in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by C Caroline Blackwell in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Division of Molecular Medicine, Pathology North, Newcastle, New South Wales, Australia
Search for other papers by Rodney J Scott in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Eugenie R Lumbers in
Google Scholar
PubMed
the RAS which, via the angiotensin II type 1 receptor (AGTR1), stimulates angiogenesis and cell proliferation ( 4 , 5 , 6 ). In tissues, inactive prorenin is non-proteolytically activated by binding to the (pro)renin receptor (ATP6AP2), so it forms
Department of Endocrinology, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Anne Jouinot in
Google Scholar
PubMed
Search for other papers by Juliane Lippert in
Google Scholar
PubMed
Comprehensive Cancer Center Mainfranken, University of Wuerzburg, Wuerzburg, Germany
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Search for other papers by Bruno de La Villeon in
Google Scholar
PubMed
Search for other papers by Amandine Septier in
Google Scholar
PubMed
Search for other papers by Mario Neou in
Google Scholar
PubMed
Search for other papers by Karine Perlemoine in
Google Scholar
PubMed
Search for other papers by Silke Appenzeller in
Google Scholar
PubMed
Department of Pathology, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Mathilde Sibony in
Google Scholar
PubMed
Department of Digestive and Endocrine Surgery, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Sébastien Gaujoux in
Google Scholar
PubMed
Department of Digestive and Endocrine Surgery, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Bertrand Dousset in
Google Scholar
PubMed
Department of Endocrinology, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Rossella Libe in
Google Scholar
PubMed
Department of Endocrinology, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Lionel Groussin in
Google Scholar
PubMed
Institute of Metabolism and System Research, University of Birmingham, Birmingham, UK
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by Cristina L Ronchi in
Google Scholar
PubMed
Department of Endocrinology, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Guillaume Assié in
Google Scholar
PubMed
Department of Endocrinology, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Jérôme Bertherat in
Google Scholar
PubMed
present are the tumor extension, best reflected by the ENSAT stage ( 2 ), and the tumor proliferation, estimated either by mitotic count ( 3 ) or Ki67 proliferation index ( 4 , 5 ). However, the prognosis still varies widely among tumors with the same